Woman´s Health | Medical XPRT
News
-
Bayer expands development program for elinzanetant with Phase III study in breast cancer patients with vasomotor symptoms caused by endocrine therapy
Study plans to investigate elinzanetant as non-hormonal treatment for vasomotor symptoms caused by endocrine therapy in breast cancer patients Elinzanetant is an innovative non-hormonal development compound in development for the treatment ...
Equipment & Solutions
-
Showcase
Urine HCG Rapid Test Kit
This product uses double antibody sandwich immunochromatography technology to achieve in vitro qualitative detection of HCG in Human urine,which is not used for the detection of trophoblastic tumors.